Organisation
Laboratory for Tumor Immunology and Immunotherapy
Division
In June 2016, the Laboratory of Tumor Immunology and Immunotherapy was founded at KU Leuven. In 2019 Prof An Coosemans, MD PhD, was appointed as the head of the lab. Currently, the lab counts one post-doc, four PhD students, one biostatistician and two lab technicians. The research philosophy of the lab is highly translational. By unraveling the immune biology in patients at diagnosis and during therapy/clinical trials (immune profiling), we can develop more rational based immunotherapy approaches (in mouse models). Immunotherapeutic approaches arise from academic and industry collaborations. Our preclinical findings have already been and will be the basis for well-established clinical trials in the future. The focus is mainly on ovarian cancer, glioblastoma and uterine sarcoma.
Follow our research on:
www.LTII.be